In contrast, postprandial active GIPbioassay level in T2DM subjects without DPP-4 inhibitor tended to be lower than those in NGT, as well as total GIP ELISA and active GIP ELISA levels (Figures 2A–C). The gene discussed is GIP; the disease is type 2 diabetes mellitus.